miRNA-based signatures in cerebrospinal fluid as potential diagnostic tools for early stage Parkinson’s disease MCT Dos Santos, MA Barreto-Sanz, BRS Correia, R Bell, C Widnall, ... Oncotarget 9 (25), 17455, 2018 | 107 | 2018 |
Evaluation of cerebrospinal fluid proteins as potential biomarkers for early stage Parkinson’s disease diagnosis MC T. dos Santos, D Scheller, C Schulte, IR Mesa, P Colman, SR Bujac, ... PLoS One 13 (11), e0206536, 2018 | 34 | 2018 |
N-terminal acetylation of α-synuclein slows down its aggregation process and alters the morphology of the resulting aggregates R Bell, RJ Thrush, M Castellana-Cruz, M Oeller, R Staats, A Nene, ... Biochemistry 61 (17), 1743-1756, 2022 | 29 | 2022 |
Modulation of the interactions between α-synuclein and lipid membranes by post-translational modifications R Bell, M Vendruscolo Frontiers in neurology 12, 661117, 2021 | 29 | 2021 |
Effects of N-terminal acetylation on the aggregation of disease-related α-synuclein variants R Bell, M Castellana-Cruz, A Nene, RJ Thrush, CK Xu, JR Kumita, ... Journal of Molecular Biology 435 (1), 167825, 2023 | 23 | 2023 |
Sequence-based prediction of pH-dependent protein solubility using CamSol M Oeller, R Kang, R Bell, H Ausserwöger, P Sormanni, M Vendruscolo Briefings in Bioinformatics 24 (2), bbad004, 2023 | 20 | 2023 |
Recent developments in circulating biomarkers in Parkinson’s disease: the potential use of miRNAs in a clinical setting MC Teixeira dos Santos, R Bell, AN da Costa Bioanalysis 8 (23), 2497-2518, 2016 | 20 | 2016 |
Probing the effects of N-terminal acetylation on α-synuclein structure, aggregation and cytotoxicity R Bell, M Vendruscolo, JR Kumita Methods in Enzymology 686, 45-65, 2023 | 1 | 2023 |
Assessing the impact of N-terminal acetylation on the aggregation of alpha-synuclein and its disease-related mutants R Bell | | 2022 |